CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 15 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,025,000 | -51.4% | 559,900 | 0.0% | 0.31% | -58.2% |
| Q2 2017 | $2,111,000 | +2.5% | 559,900 | 0.0% | 0.75% | +0.5% |
| Q1 2017 | $2,060,000 | +8.2% | 559,900 | +55.6% | 0.74% | -26.6% |
| Q4 2016 | $1,904,000 | -11.8% | 359,900 | 0.0% | 1.02% | +13.4% |
| Q3 2016 | $2,159,000 | – | 359,900 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|